Viewing Study NCT01896856

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:18 PM
Ignite Modification Date: 2026-05-29 @ 12:03 PM
Study NCT ID: NCT01896856
Status: COMPLETED
Last Update Posted: 2020-10-06
First Post: 2013-07-08
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Phase I/II Study of SGI-110 With Irinotecan Versus Regorafenib or TAS-102 in Metastatic Colorectal Cancer
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Previously Treated Metastatic Colorectal Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None SGI-110 View
None irinotecan View
None regorafenib View
None methylation View
None colorectal View
None metastatic View
None TAS-102 View
None lonsurf View